Clincosm LogoSign in Get a demo

time in range

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Time in Range Trial in Cairo (Dipeptidyl peptidase-4 inhibitors)

Completed
  • Time in Range
  • Dipeptidyl peptidase-4 inhibitors
  • Cairo, Egypt
    Nancy Elbarbary
Aug 26, 2023

Type2diabetes, Pregnancy Related, Continuous Glucose Monitoring Trial in Beijing (Real-time Continuous Glucose Monitoring

Recruiting
  • Type2diabetes
  • +4 more
  • Real-time Continuous Glucose Monitoring System
  • Beijing, Beijing, China
    Peking University Third Hospital
Jul 8, 2023

Time in Range, Artificial Intelligence, Insulin Therapy Trial in Jingan (Wechat program)

Recruiting
  • Time in Range
  • +2 more
  • Wechat program
  • Shanghai, Shanghai, China
    Xiaolong Zhao
Oct 21, 2022

T2DM (Type 2 Diabetes), Needle-free Injector, Time in Range Trial in China (Needle-free injector, Insulin pen)

Recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • +2 more
  • Needle-free injector
  • Insulin pen
  • Changxing, Zhejiang, China
  • +20 more
Aug 30, 2021

Type 1 Diabetes With Diabetic Gastroparesis, HbA1c, Time in Range Trial in Hangzhou (insulin degludec/insulin aspart (IDegAsp),

Recruiting
  • Type 1 Diabetes Mellitus With Diabetic Gastroparesis
  • +2 more
  • insulin degludec/insulin aspart (IDegAsp)
  • basal insulin plus pre-prandial insulin
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jul 7, 2021

The Use of Faster Acting Aspart in Type 1 Diabetes Patients

Completed
  • Type 1 Diabetes
  • +2 more
    • Edegem, Antwerp, Belgium
      Antwerp University Hospital
    Jan 12, 2021